SCHEMBL8230392

SCHEMBL8230392

CCOP(=O)(COc1ccc(CCNC(=O)OC(C)(C)C)cc1)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.47
KMT2A Q03164 1/20 0.47
CA1 P00915 7/20 0.45
CA2 P00918 7/20 0.45
CA12 O43570 5/20 0.45
CA9 Q16790 5/20 0.45
ACACB O00763 3/20 0.44
NPC1 O15118 2/20 0.44
MAPT P10636 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NAMPT P43490 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
TAS1R2 Q8TE23 1/20 0.42
CTSK P43235 1/20 0.41
PTPN1 P18031 1/20 0.41
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14763270 0.88 CA1 (0.49) GLAKMT2ACA1CA2CA12
SCHEMBL8728998 0.85 CA2 (0.48) GLAKMT2ACA1CA2CA12
SCHEMBL27741033 0.85 ACACB (0.59) GLAKMT2ACA1CA2CA12
SCHEMBL5142116 0.83 GLA (0.49) GLAKMT2ACA1CA2CA12
SCHEMBL27460864 0.83 PTPN1 (0.47) GLAKMT2ACA1CA2NPC1
SCHEMBL14812122 0.81 CA2 (0.48) GLAKMT2ACA1CA2MAPT
SCHEMBL19003451 0.80 ACACB (0.61) GLAKMT2ACA1CA2CA12
SCHEMBL13618081 0.80 ACACB (0.53) GLAKMT2ACA1CA2CA12
SCHEMBL27460037 0.79 PTPN1 (0.47) GLAKMT2ACA1CA2CA12
SCHEMBL23291155 0.79 CA1 (0.55) GLAKMT2ACA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069303-B1 ANTIVIRAL PROTEASE INHIBITORS GILEAD SCIENCES INC (US) 2016-03-30 EP disclosed
WO-2008011117-A2 ANTIVIRAL PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2008-01-24 WO disclosed